| |
|
Form Serial Number: |
CS20180612E00224
(Superseded by CS20180619E00347) |
| 1.
Date of relevant event: |
07/06/2018
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
01548 |
| 4.
Name of listed corporation: |
Genscript Biotech Corporation |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
1,758,085,795 |
| 7.
Name of substantial shareholder: |
Genscript Corporation |
| 8.
Registered office: |
Suite 606, 1220 N. Market Street, Wilmington, DE 19801, County of New Castle, USA |
| 9.
Principal place of business in Hong Kong: |
香港灣仔皇后大道東28號金鐘匯中心18樓 |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1209 | The percentage level of your interest in the shares has reduced because:
you placed the shares to placee(s) under a top-up placing |
|
|
|
75,000,000 |
HKD |
|
|
26.5000 |
|
| Short position |
| 1503 | You ceased to have a short position of 1% or more in the shares, or the percentage level of your short position in such shares decreased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
|
|
75,000,000 |
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 887,402,024 | 50.47 |
| Short position | 75,000,000 | 4.26 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 812,402,024 | 46.20 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| Zhang Fangliang | Addresses of individuals are not displayed. | | 6104 | Controller is a director |
| 28.83 |
|
| |
| 27.
Supplementary information: |
The shareholder released its obligation to place 75,000,000 of the Company's ordinary shares on 7 June 2018 pursuant to a placing and subscription agreement dated 5 June 2018.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
12/06/2018
(dd/mm/yyyy)
|
|
|
|
|